Infectious Disease Biochemistry and molecular biology Clinical care Molecular Pathology Screening and monitoring Technology and innovation Laboratory management

Inside the CDC’s Warning on Drug-Resistant Infections

In a race against time – and resources – pathologists are bridging diagnostics with stewardship to outpace resistant infections

11/07/2025 Discussion 5 min read

article Full Article Summary Notecard

Share

Rise in drug-resistant infections, particularly CPOs.
CDC report emphasizes need for enhanced laboratory detection.
NDM now exceeds KPC as most common carbapenemase.
Importance of mechanism-guided therapy highlighted.
Labs must utilize specific testing methods for effective detection.
Collaboration between microbiologists and infection teams is essential.
Facilities should prioritize resistance testing to adapt to evolving patterns.